Literature DB >> 20186498

Oversight of financial conflicts of interest in commercially sponsored research in academic and nonacademic settings.

Kevin P Weinfurt1, Mark A Hall, N Chantelle Hardy, Joëlle Y Friedman, Kevin A Schulman, Jeremy Sugarman.   

Abstract

BACKGROUND: Studies of conflicts of interest in clinical research have focused on academic centers, but most clinical research takes place in nonacademic settings.
OBJECTIVE: To compare oversight and management of investigators' financial relationships in academic and nonacademic research settings. DESIGN, SETTING, AND PARTICIPANTS: Survey of officials at 199 sites that contributed participants to commercially sponsored phase 3 clinical trials published in JAMA or the New England Journal of Medicine in 2006 and 2007.
MEASUREMENTS AND MAIN RESULTS: Response rates were 66% for academic medical centers, 37% for nonacademic medical centers (inpatient), and 27% for outpatient nonacademic sites. Almost all academic medical centers (97%) and most nonacademic medical centers (87%) followed written conflict-of-interest policies, whereas 44% of outpatient nonacademic sites had written policies (P < 0.001). Academic and nonacademic medical centers relied mainly on internal institutional review boards (69% and 71%, respectively); outpatient nonacademic sites relied primarily on independent institutional review boards (59%; P < 0.001).
CONCLUSIONS: Nonacademic sites have substantially different approaches to the oversight and management of financial relationships in commercially sponsored clinical research than academic medical centers. These differences warrant more attention to how financial relationships are monitored in community research settings.

Entities:  

Mesh:

Year:  2010        PMID: 20186498      PMCID: PMC2854996          DOI: 10.1007/s11606-010-1264-6

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  13 in total

1.  A national survey of policies on disclosure of conflicts of interest in biomedical research.

Authors:  S V McCrary; C B Anderson; J Jakovljevic; T Khan; L B McCullough; N P Wray; B A Brody
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

2.  Conflict-of-interest policies for investigators in clinical trials.

Authors:  B Lo; L E Wolf; A Berkeley
Journal:  N Engl J Med       Date:  2000-11-30       Impact factor: 91.245

3.  Conflicts of interest in biomedical research.

Authors:  D Korn
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

4.  Policies on faculty conflicts of interest at US universities.

Authors:  M K Cho; R Shohara; A Schissel; D Rennie
Journal:  JAMA       Date:  2000-11-01       Impact factor: 56.272

5.  Protecting subjects, preserving trust, promoting progress I: policy and guidelines for the oversight of individual financial interests in human subjects research.

Authors: 
Journal:  Acad Med       Date:  2003-02       Impact factor: 6.893

Review 6.  Scope and impact of financial conflicts of interest in biomedical research: a systematic review.

Authors:  Justin E Bekelman; Yan Li; Cary P Gross
Journal:  JAMA       Date:  2003 Jan 22-29       Impact factor: 56.272

7.  Implementation of financial disclosure policies to manage conflicts of interest.

Authors:  Elizabeth A Boyd; Shira Lipton; Lisa A Bero
Journal:  Health Aff (Millwood)       Date:  2004 Mar-Apr       Impact factor: 6.301

8.  Policies of academic medical centers for disclosing financial conflicts of interest to potential research participants.

Authors:  Kevin P Weinfurt; Michaela A Dinan; Jennifer S Allsbrook; Joëlle Y Friedman; Mark A Hall; Kevin A Schulman; Jeremy Sugarman
Journal:  Acad Med       Date:  2006-02       Impact factor: 6.893

9.  Patients' views on financial conflicts of interest in cancer research trials.

Authors:  Lindsay A Hampson; Manish Agrawal; Steven Joffe; Cary P Gross; Joel Verter; Ezekiel J Emanuel
Journal:  N Engl J Med       Date:  2006-11-30       Impact factor: 91.245

10.  Community hospital oversight of clinical investigators' financial relationships.

Authors:  Mark A Hall; Kevin P Weinfurt; Janice S Lawlor; Joëlle Y Friedman; Kevin A Schulman; Jeremy Sugarman
Journal:  IRB       Date:  2009 Jan-Feb
View more
  4 in total

1.  Exploring the Potential for Moral Hazard When Clinical Trial Research is Conducted in Rural Communities: Do Traditional Ethics Concepts Apply?

Authors:  Ann Freeman Cook; Helena Hoas
Journal:  HEC Forum       Date:  2015-06

2.  What adolescents enrolled in genomic addiction research want to know about conflicts of interest.

Authors:  Marilyn E Coors; Kristen M Raymond; Shannon K McWilliams; Christian J Hopfer; Susan K Mikulich-Gilbertson
Journal:  Drug Alcohol Depend       Date:  2014-12-15       Impact factor: 4.492

3.  Association of medical students' reports of interactions with the pharmaceutical and medical device industries and medical school policies and characteristics: a cross-sectional study.

Authors:  James S Yeh; Kirsten E Austad; Jessica M Franklin; Susan Chimonas; Eric G Campbell; Jerry Avorn; Aaron S Kesselheim
Journal:  PLoS Med       Date:  2014-10-14       Impact factor: 11.069

4.  United States private-sector physicians and pharmaceutical contract research: a qualitative study.

Authors:  Jill A Fisher; Corey A Kalbaugh
Journal:  PLoS Med       Date:  2012-07-24       Impact factor: 11.069

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.